EW
EW
EW
EW NASDAQ
Edwards Lifesciences Corporation recently saw Beacon Pointe Advisors LLC acquire 128,603 shares, according to defenseworld.net. The company currently holds a market capitalization of approximately 51.76 billion with an annual revenue of 6.07 billion. Alongside these figures, the stock trades at a PE ratio of roughly 51.67, with a TTM EPS of 1.74 and a free cash flow yield of 2.77%.
Based on defenseworld.net128,603 Shares in Edwards Lifesciences Corporation $EW Acquired by Beacon Pointe Advisors LLC
Is EW Overvalued? DCF Says Worth $53
Bank of Nova Scotia Takes Position in Edwards Lifesciences Corporation $EW
37,702 Shares in Edwards Lifesciences Corporation $EW Bought by EP Wealth Advisors LLC
B. Metzler seel. Sohn & Co. AG Buys Shares of 41,753 Edwards Lifesciences Corporation $EW
Allworth Financial LP Takes Position in Edwards Lifesciences Corporation $EW
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.